AKT1 and metabolic disease: AMPK and PI3K/Akt signaling pathways may be involved in diabetes-induced cognitive decline, and DL-3-n-butylphthalide ameliorates diabetes-associated cognitive decline by enhancing PI3K/Akt signaling [41].AMPK may be a fundamental cellular pathway for metabolic disorders and diabetes [42].